Clearance Summary
BD INSULIN SYRINGE received FDA 510(k) clearance under submission number K024112, sponsored by Becton, Dickinson & CO. The device was reviewed via the Special premarket notification pathway and assigned to the General Hospital review panel. The statutory decision date of record is 2003-01-09.
- Submission: K024112
- Applicant / Sponsor: Becton, Dickinson & CO
- Clearance pathway: Special
- Review panel: General Hospital
- Device class: Class II
- Regulation citation: 21 CFR 880.5860
- Decision date: 2003-01-09
Classification & Regulation
This clearance is catalogued under FDA product code FMF and 21 CFR 880.5860, within the General Hospital review panel as a Class II device.